Key result
Waon therapy linked to ~42% increased flow-mediated dilation and improved LVEF in chronic heart failure.
Why the study?
Does Waon therapy improve quality of life, cardiac function, and exercise capacity in patients with chronic heart failure?
Does Waon therapy improve quality of life, cardiac function, and exercise capacity in patients with chronic heart failure?
Absolute Event Rate: 5.1% vs 3.6%
p-value: p=<0.01
A 3-week course of Waon therapy (repeated sauna therapy) improves quality of life, cardiac function, and exercise capacity in patients with chronic heart failure.
No takes yet. Share an insight, caveat, or question.
Waon therapy may support adjunctive use in CHF; leaves open confirmation in randomized trials.
Sobajima et al. (2015) studied Chronic Heart Failure (n=49). Waon therapy vs. Baseline (no control group) was evaluated on Flow-mediated dilation (FMD) of the brachial artery (p=<0.01). Three weeks of Waon therapy significantly improved flow-mediated dilation (from 3.6% to 5.1%), left ventricular ejection fraction, exercise capacity, and quality of life in patients with chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: